Pear Therapeutics to Go Public in Roughly $1.6 Billion SPAC Deal (The Wall Street Journal):
Medical technology company Pear Therapeutics Inc. has agreed to go public by merging with a blank-check company with ties to the Pritzker Vlock Family Office, betting on the growing role of prescription digital therapeutics.
The proposed merger would give the combined company a pro forma equity value of about $1.6 billion. [Read more…] about Prescription software firm Pear Therapeutics to go public via $1.6 billion SPAC deal, harnessing 3 FDA-authorized products and 14 candidates